Tyvaso Dosing and Titration Evaluation: TyTRATE Registry

Completed

Conditions studied: Pulmonary Arterial Hypertension

In brief

This prospective, observational, multi-center, patient registry will follow patients who are newly initiated on Tyvaso for the treatment of Pulmonary Arterial Hypertension (PAH). Once enrolled, the patients' dose and titration will be followed for the first 6 months of treatment with Tyvaso. A call-center will contact the patients directly at weeks 1, 2, 3, 4, 8, 12, 16, 20, and 24 to review their dose and titration schedule. In addition to patient-reported dosing data, some patient demographic information, will be collected by the investigative site at Baseline.

Key facts

Study ID

NCT01799473

Run by

United Therapeutics

People needed

98

Starts

2013-01-01

Expected to finish

2014-12-01

Last updated by the study team

2015-03-24

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Are newly prescribed Tyvaso for the treatment of PAH and plan to initiate therapy
• Are willing and able to be contacted by the patient call center.

You may not qualify if…

• Have previously received Tyvaso.
• Are currently enrolled in an interventional (non-FDA approved) PH clinical trial.

Where it is running

• UCLA Medical Center — Los Angeles, California, United States
• Southern California Permanente — Pasadena, California, United States
• Central Coast Chest Consultants — San Luis Obispo, California, United States
• Pacific Sleep Disorders Center — Stockton, California, United States
• Prime Healthcare, PC — West Hartford, Connecticut, United States
• Bay Area Cardiology Associates, PA — Brandon, Florida, United States
• Florida Lung & Sleep Specialist — Celebration, Florida, United States
• Study site — Jacksonville, Florida, United States
• Sacred Heart Medical Group — Miramar Beach, Florida, United States
• Cardiology Consultants — Pensacola, Florida, United States
• Pensacola Lung Group — Pensacola, Florida, United States
• Sacred Heart Medical Group — Pensacola, Florida, United States
• Pediatrix Cardiology Associates — Tampa, Florida, United States
• Doctors Hospital of Augusta — Augusta, Georgia, United States
• On Site Clinical Solutions — Cumming, Georgia, United States
• Duluth Biomedical Research — Duluth, Georgia, United States
• Gwinnett Consultants in Cardiology — Lawrenceville, Georgia, United States
• Atlanta Cardiology Consultants — Roswell, Georgia, United States
• Queens Medical Center - Honolulu — ‘Aiea, Hawaii, United States
• Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois, United States
• Dor Heart and Vascular Clinic — Gurnee, Illinois, United States
• Loyola University of Chicago — Maywood, Illinois, United States
• Advocate Medical Group — Oak Brook, Illinois, United States
• Methodist Medical Center of Illinois — Peoria, Illinois, United States
• The Regents of the University of California — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.